Cargando…
Antibody Conjugates-Recent Advances and Future Innovations
Monoclonal antibodies have evolved from research tools to powerful therapeutics in the past 30 years. Clinical success rates of antibodies have exceeded expectations, resulting in heavy investment in biologics discovery and development in addition to traditional small molecules across the industry....
Autores principales: | Leung, Donmienne, Wurst, Jacqueline M., Liu, Tao, Martinez, Ruben M., Datta-Mannan, Amita, Feng, Yiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148502/ https://www.ncbi.nlm.nih.gov/pubmed/31936270 http://dx.doi.org/10.3390/antib9010002 |
Ejemplares similares
-
Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules
por: Datta-Mannan, Amita, et al.
Publicado: (2021) -
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
por: Tsuchikama, Kyoji, et al.
Publicado: (2016) -
Antibody–drug conjugates: Recent advances in payloads
por: Wang, Zhijia, et al.
Publicado: (2023) -
Recent advances of antibody drug conjugates for clinical applications
por: Zhao, Pengxuan, et al.
Publicado: (2020) -
Antibody–drug conjugates: Recent advances in linker chemistry
por: Su, Zheng, et al.
Publicado: (2021)